The Clinical Research of Traditional Chinese Medicine Compound Formulas
Status:
NOT_YET_RECRUITING
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Phase:
PHASE4
Details
Lead Sponsor:
The Fourth Affiliated Hospital of Zhejiang University School of Medicine